Search research articles
Contact Us
Filters
Showing results (181-190 of 237) with videos related to
Page
of 24
Sort By:
Journal of Surgical Oncology
|
December 23, 2011
Operative management for recurrent and metastatic adrenocortical carcinoma
Nicole M Datrice, Russell C Langan, R Taylor Ripley, et al.
Mutation Research
|
June 2, 2005
The extent of chromosomal aberrations induced by chemotherapy in non-human primates depends on the schedule of administration
V Koneti Rao, Turid Knutsen, Thomas Ried, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
January 16, 2023
Baseline Radiomic Signature to Estimate Overall Survival in Patients With NSCLC
Laurent Dercle, Matthew Fronheiser, Naiyer A Rizvi, et al.
Endocrine-Related Cancer
|
December 15, 2011
False-negative ¹²³I-MIBG SPECT is most commonly found in SDHB-related pheochromocytoma or paraganglioma with high frequency to develop metastatic disease
Jay S Fonte, Jeremyjones F Robles, Clara C Chen, et al.
Ebiomedicine
|
August 24, 2024
Assessing olaparib efficacy in U.S. Veterans with metastatic prostate cancer utilizing a time-indifferent g-rate method ideal for real-world analyses
Harshraj Leuva, Mengxi Zhou, Nader Jamaleddine, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 2, 2003
Phase I trial and pharmacokinetic study of BMS-247550, an epothilone B analog, administered intravenously on a daily schedule for five days
Jame Abraham, Manish Agrawal, Susan Bakke, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 26, 2010
Tumor regression and growth rates determined in five intramural NCI prostate cancer trials: the growth rate constant as an indicator of therapeutic efficacy
Wilfred D Stein, James L Gulley, Jeff Schlom, et al.
Cancer
|
May 17, 2002
A phase II trial of combination chemotherapy and surgical resection for the treatment of metastatic adrenocortical carcinoma: continuous infusion doxorubicin, vincristine, and etoposide with daily mitotane as a P-glycoprotein antagonist
Jame Abraham, Susan Bakke, Ann Rutt, et al.
Cancer Research
|
October 19, 2005
Genetic and epigenetic modeling of the origins of multidrug-resistant cells in a human sarcoma cell line
Kevin G Chen, Yan C Wang, Marci E Schaner, et al.
Leukemia & Lymphoma
|
September 21, 2025
From dimensions through dynamics to outcomes - lymph nodes and skin assessments predict CTCL outcomes
Alexander Kaminsky, Lauren M Fahmy, Zaid Bilgrami, et al.
Page
of 24
Search research articles
Search
Showing results (181-190 of 237) with videos related to
Sort By:
Page
of 24
Journal of Surgical Oncology
|
December 23, 2011
Operative management for recurrent and metastatic adrenocortical carcinoma
Nicole M Datrice, Russell C Langan, R Taylor Ripley, et al.
Mutation Research
|
June 2, 2005
The extent of chromosomal aberrations induced by chemotherapy in non-human primates depends on the schedule of administration
V Koneti Rao, Turid Knutsen, Thomas Ried, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
January 16, 2023
Baseline Radiomic Signature to Estimate Overall Survival in Patients With NSCLC
Laurent Dercle, Matthew Fronheiser, Naiyer A Rizvi, et al.
Endocrine-Related Cancer
|
December 15, 2011
False-negative ¹²³I-MIBG SPECT is most commonly found in SDHB-related pheochromocytoma or paraganglioma with high frequency to develop metastatic disease
Jay S Fonte, Jeremyjones F Robles, Clara C Chen, et al.
Ebiomedicine
|
August 24, 2024
Assessing olaparib efficacy in U.S. Veterans with metastatic prostate cancer utilizing a time-indifferent g-rate method ideal for real-world analyses
Harshraj Leuva, Mengxi Zhou, Nader Jamaleddine, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 2, 2003
Phase I trial and pharmacokinetic study of BMS-247550, an epothilone B analog, administered intravenously on a daily schedule for five days
Jame Abraham, Manish Agrawal, Susan Bakke, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 26, 2010
Tumor regression and growth rates determined in five intramural NCI prostate cancer trials: the growth rate constant as an indicator of therapeutic efficacy
Wilfred D Stein, James L Gulley, Jeff Schlom, et al.
Cancer
|
May 17, 2002
A phase II trial of combination chemotherapy and surgical resection for the treatment of metastatic adrenocortical carcinoma: continuous infusion doxorubicin, vincristine, and etoposide with daily mitotane as a P-glycoprotein antagonist
Jame Abraham, Susan Bakke, Ann Rutt, et al.
Cancer Research
|
October 19, 2005
Genetic and epigenetic modeling of the origins of multidrug-resistant cells in a human sarcoma cell line
Kevin G Chen, Yan C Wang, Marci E Schaner, et al.
Leukemia & Lymphoma
|
September 21, 2025
From dimensions through dynamics to outcomes - lymph nodes and skin assessments predict CTCL outcomes
Alexander Kaminsky, Lauren M Fahmy, Zaid Bilgrami, et al.
Page
of 24